期刊
DIABETOLOGIA
卷 58, 期 9, 页码 1978-1992出版社
SPRINGER
DOI: 10.1007/s00125-015-3680-y
关键词
Biomarkers; Circulating microRNAs; Diabetes; Human studies; Review
资金
- INSERM
- Universite Nice Sophia Antipolis
- Conseil Regional PACA
- Conseil General des Alpes-Maritimes
- Aviesan/AstraZeneca
- Agence Nationale de la Recherche (ANR) [ANR-RPV12004AAA]
- 'Investments for the Future' LABEX SIGN ALIFE [ANR-11-LABX-0028-01]
- European Foundation for the Study of Diabetes (EFSD/Lilly
- European Diabetes Research Programme)
The explosive increase in the worldwide prevalence of diabetes over recent years has transformed the disease into a major public health concern. While diabetes can be screened for and diagnosed by reliable biological tests based on blood glucose levels, by and large there are no means of detecting at-risk patients or of following diabetic complications. The recent discovery that microRNAs are not only chief intracellular players in many biological processes, including insulin secretion and action, but are also circulating, has put them in the limelight as possible biological markers. Here we discuss the potential role of circulating microRNAs as biomarkers in the context of diabetes and its associated complications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据